The BCR::ABL1 fusion gene, resulting from the t(9;22) chromosomal translocation (Figure 3), is the hallmark of CML and drives disease pathogenesis through constitutive tyrosine kinase activity. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.